Evidence map›Paper›PMID 29161540›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2018

Delirium symptoms are associated with decline in cognitive function between ages 53 and 69 years: Findings from a British birth cohort study.

Alex Tsui, Diana Kuh, Marcus Richards, Daniel Davis

Abstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Alex TsuiMRC Unit for Lifelong Health and Ageing at UCL, London, UK. Electronic address: a.tsui@ucl.ac.uk.
Diana KuhMRC Unit for Lifelong Health and Ageing at UCL, London, UK.
Marcus RichardsMRC Unit for Lifelong Health and Ageing at UCL, London, UK.
Daniel DavisMRC Unit for Lifelong Health and Ageing at UCL, London, UK.

Funding

Medical Research Council MC_UU_12019/1Medical Research Council MC_UU_12019/3Wellcome Trust
6 · The paper itself

Abstract

introductionFew population studies have investigated whether longitudinal decline after delirium in mid-to-late life might affect specific cognitive domains.

methodsParticipants from a birth cohort completing assessments of search speed, verbal memory, and the Addenbrooke's Cognitive Examination at age 69 were asked about delirium symptoms between ages 60 and 69 years. Linear regression models estimated associations between delirium symptoms and cognitive outcomes.

resultsPeriod prevalence of delirium between 60 and 69 years was 4% (95% confidence interval 3.2%-4.9%). Self-reported symptoms of delirium over the seventh decade were associated with worse scores in the Addenbrooke's Cognitive Examination (-1.7 points; 95% confidence interval -3.2, -0.1; P = .04). In association with delirium symptoms, verbal memory scores were initially lower, with subsequent decline in search speed by the age of 69 years. These effects were independent of other Alzheimer's risk factors. DISCUSSION: Delirium symptoms may be common even at relatively younger ages, and their presence may herald cognitive decline, particularly in search speed, over this time period.

Indexed as

AgedCognitive DysfunctionCohort StudiesDeliriumFemaleHumansLongitudinal StudiesMaleMiddle AgedNeuropsychological TestsRisk FactorsUnited KingdomCognitive declineDeliriumDementiaLife course

Identifiers

PMID29161540
PMCPMC5948100

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.